Although flourishing numbers of researches have demonstrated that the existence of HMGB1 polymorphism made it possible for affecting the susceptibility [27–36], prognosis [15,37,38] as well as treatment response of malignancies [39], the correlation between HMGB1 polymorphism and risks of cancer remains controversial. The gene discussed is HMGB1; the disease is cancer.